Physician profile
Peter L Smith
NPI 1861497224
$1,106.87
in general payments reported to CMS, 2019-2025
10 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $24.93 · 2022: $249 · 2023: $155 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $511.98 | 2019 | |
| Sirtex Medical INC | $159.06 | 2019-2023 | Sir-Spheres Microspheres |
| Penumbra, INC. | $126.94 | 2025 | Indigo System |
| Medtronic, INC. | $107.80 | 2022 | |
| Janssen Pharmaceuticals, INC | $107.78 | 2022 | |
| Medtronic USA, INC. | $24.93 | 2020 | |
| Abbott Laboratories | $21.75 | 2019 | |
| Inari Medical, INC. | $20.72 | 2022 | |
| Cashflow Solutions, LLC | $12.97 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Bard Peripheral Vascular, INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.